Probucol prevents blood-brain barrier dysfunction in wild-type mice induced by saturated fat or cholesterol feeding
| Main Authors: | Takechi, Ryu, Galloway, Susan, Pallebage-Gamarallage, Menuka, Lam, Virginie, Dhaliwal, Satvinder, Mamo, John |
|---|---|
| Format: | Journal Article |
| Published: |
Wiley-Blackwell Publishing Asia
2013
|
| Online Access: | http://hdl.handle.net/20.500.11937/49646 |
Similar Items
Probucol Suppresses Enterocytic Accumulation of Amyloid-β Induced by Saturated Fat and Cholesterol Feeding
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2011)
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2011)
Probucol Reduces Enterocytic Amyloid-beta Relative to Chylomicron Apolipoprotein B in Mice Chronically Fed Saturated Fats
by: Takechi, Ryu, et al.
Published: (2010)
by: Takechi, Ryu, et al.
Published: (2010)
Long-term probucol therapy continues to suppress markers of neurovascular inflammation in a dietary induced model of cerebral capillary dysfunction
by: Takechi, Ryu, et al.
Published: (2014)
by: Takechi, Ryu, et al.
Published: (2014)
Nutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood-brain barrier function in wild-type mice
by: Takechi, Ryusuke, et al.
Published: (2013)
by: Takechi, Ryusuke, et al.
Published: (2013)
A Diet Enriched in Docosahexanoic Acid Exacerbates Brain Parenchymal Extravasation of Apo B Lipoproteins Induced by Chronic Ingestion of Saturated Fats
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2012)
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2012)
Restoration of dietary-fat induced blood-brain barrier dysfunction by anti-inflammatory lipid-modulating agents
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2012)
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2012)
Nicotine Attenuates Disruption of Blood-Brain Barrier Induced by Saturated-Fat Feeding in Wild-Type Mice.
by: Elahy, M., et al.
Published: (2015)
by: Elahy, M., et al.
Published: (2015)
The Effect of Atorvastatin, Pravastatin and Ibuprofen on Dietary-Fat Induced Disturbances in Blood-Brain Barrier Function
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2010)
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2010)
Probucol prevents blood–brain barrier dysfunction and cognitive decline in mice maintained on pro-diabetic diet
by: Mamo, John, et al.
Published: (2018)
by: Mamo, John, et al.
Published: (2018)
Synergistic effects of high fat feeding and apolipoprotein E deletion on enterocytic amyloid-beta abundance.
by: Galloway, Susan, et al.
Published: (2008)
by: Galloway, Susan, et al.
Published: (2008)
The effect of exogenous cholesterol and lipid modulating agents on apolipoprotein B and amyloid-beta abundance in the absorptive epithelial cells of the small intestine
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2008)
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2008)
Aging-Related Changes in Blood-Brain Barrier Integrity and the Effect of Dietary Fat
by: Takechi, Ryusuke, et al.
Published: (2012)
by: Takechi, Ryusuke, et al.
Published: (2012)
Colocalisation of plasma derived apo B lipoproteins with cerebral proteoglycans in a transgenic-amyloid model of Alzheimer's disease
by: Lam, Virginie, et al.
Published: (2011)
by: Lam, Virginie, et al.
Published: (2011)
Post-prandial lipid metabolism, lipid-modulating agents and cerebrovascular integrity: Implications for dementia risk
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2010)
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2010)
Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk
by: Takechi, Ryu, et al.
Published: (2010)
by: Takechi, Ryu, et al.
Published: (2010)
Differential effects of saturated fatty acid, monounsaturated fatty acid and polyunsaturated fatty acid on chylomicron metabolism in the small intestine
by: Galloway, S., et al.
Published: (2008)
by: Galloway, S., et al.
Published: (2008)
The differential effects of fatty acids on enterocytic abundance of amyloid-beta
by: Galloway, Susan, et al.
Published: (2019)
by: Galloway, Susan, et al.
Published: (2019)
Pharmacological modulation of dietary lipid-induced cerebral capillary dysfunction: Considerations for reducing risk for Alzheimer’s disease
by: Pallebage-Gamarallage, M., et al.
Published: (2015)
by: Pallebage-Gamarallage, M., et al.
Published: (2015)
The effects of long-term saturated fat enriched diets on the brain lipidome
by: Giles, C., et al.
Published: (2016)
by: Giles, C., et al.
Published: (2016)
Amyloid-beta colocalizes with apolipoprotein B in absorptive cells of the small intestine
by: Galloway, Susan, et al.
Published: (2009)
by: Galloway, Susan, et al.
Published: (2009)
The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-beta abundance
by: Galloway, Susan, et al.
Published: (2009)
by: Galloway, Susan, et al.
Published: (2009)
Differential Effects of High-Protein Diets Derived from Soy and Casein on Blood-Brain Barrier Integrity in Wild-type Mice
by: Snelson, Matthew, et al.
Published: (2017)
by: Snelson, Matthew, et al.
Published: (2017)
Disruption of blood-brain barrier function by chronic intake of saturated fat and cholesterol : implications for Alzheimer’s disease risk
by: Takechi, Ryusuke
Published: (2010)
by: Takechi, Ryusuke
Published: (2010)
Three-dimensional colocalization analysis of plasma-derived apolipoprotein B with amyloid plaques in APP/PS1 transgenic mice
by: Takechi, Ryu, et al.
Published: (2009)
by: Takechi, Ryu, et al.
Published: (2009)
Effect of fatty acids on enterocytic beta-amyloid abundance: Possible aetiology in Alzheimer’s disease
by: Galloway, S., et al.
Published: (2008)
by: Galloway, S., et al.
Published: (2008)
Anti-hypertensive agents do not prevent blood-brain barrier dysfunction and cognitive deficits in dietary-induced obese mice
by: Mamo, John, et al.
Published: (2017)
by: Mamo, John, et al.
Published: (2017)
Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-beta
by: Takechi, Ryu, et al.
Published: (2010)
by: Takechi, Ryu, et al.
Published: (2010)
Chylomicron amyloi-beta in the aetiology of Alzheimer's disease
by: Takechi, Ryu, et al.
Published: (2008)
by: Takechi, Ryu, et al.
Published: (2008)
Sodium alginate capsulation increased brain delivery of probucol and suppressed neuroinflammation and neurodegeneration
by: Mamo, J., et al.
Published: (2018)
by: Mamo, J., et al.
Published: (2018)
Differential regulation of sphingolipid metabolism in plasma, hippocampus and cerebral cortex of mice administered sphingolipid modulating agents
by: Giles, Corey, et al.
Published: (2017)
by: Giles, Corey, et al.
Published: (2017)
Three-dimensional immunofluorescent double labelling using polyclonal antibodies derived from the same species: enterocytic colocalization of chylomicrons with Golgi apparatus
by: Takechi, Ryu, et al.
Published: (2008)
by: Takechi, Ryu, et al.
Published: (2008)
Nutritional and pharmacological regulation of cerebral capillary function
by: Pallebage-Gamarallage, Menuka Madhavi Somapala
Published: (2012)
by: Pallebage-Gamarallage, Menuka Madhavi Somapala
Published: (2012)
Contemporary lipidomic analytics: opportunities and pitfalls
by: Giles, C., et al.
Published: (2018)
by: Giles, C., et al.
Published: (2018)
The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory effects
by: Mooranian, Armin, et al.
Published: (2018)
by: Mooranian, Armin, et al.
Published: (2018)
Efficacy of probucol on cognitive function in Alzheimer's disease: study protocol for a double-blind, placebo-controlled, randomised phase II trial (PIA study).
by: Lam, Virginie, et al.
Published: (2022)
by: Lam, Virginie, et al.
Published: (2022)
Blood-brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment
by: Elahy, Mina, et al.
Published: (2015)
by: Elahy, Mina, et al.
Published: (2015)
Peripheral metabolism of lipoprotein-amyloid beta as a risk factor for Alzheimer's disease: potential interactive effects of APOE genotype with dietary fats
by: D'Alonzo, Zachary, et al.
Published: (2023)
by: D'Alonzo, Zachary, et al.
Published: (2023)
Adjustment of Ionized Calcium Concentration for Serum pH is not a Valid Marker of Calcium Homeostasis: Implications for Identifying Individuals at Risk of Calcium Metabolic Disorders
by: Lam, Virginie, et al.
Published: (2013)
by: Lam, Virginie, et al.
Published: (2013)
Optimising treatment parameters for the reduction of total fat, saturated fat and cholesterol in squid and prawn by lactobacillus acidophilus yoghurt using response surface methodology / Nurhafizah Ibrahim
by: Ibrahim, Nurhafizah
Published: (2007)
by: Ibrahim, Nurhafizah
Published: (2007)
Hepatic iron loading in mice increases cholesterol biosynthesis.
by: Graham, R., et al.
Published: (2010)
by: Graham, R., et al.
Published: (2010)
Similar Items
-
Probucol Suppresses Enterocytic Accumulation of Amyloid-β Induced by Saturated Fat and Cholesterol Feeding
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2011) -
Probucol Reduces Enterocytic Amyloid-beta Relative to Chylomicron Apolipoprotein B in Mice Chronically Fed Saturated Fats
by: Takechi, Ryu, et al.
Published: (2010) -
Long-term probucol therapy continues to suppress markers of neurovascular inflammation in a dietary induced model of cerebral capillary dysfunction
by: Takechi, Ryu, et al.
Published: (2014) -
Nutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood-brain barrier function in wild-type mice
by: Takechi, Ryusuke, et al.
Published: (2013) -
A Diet Enriched in Docosahexanoic Acid Exacerbates Brain Parenchymal Extravasation of Apo B Lipoproteins Induced by Chronic Ingestion of Saturated Fats
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2012)